Cargando…
Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
Psychotropics (antipsychotics, mood stabilizers, antidepressants, anxiolytics, etc.) are commonly prescribed to treat Huntington’s disease (HD). In HD preclinical models, while no psychotropic has convincingly affected huntingtin gene, HD modifying gene, or huntingtin protein expression, psychotropi...
Autor principal: | Lauterbach, Edward C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856079/ https://www.ncbi.nlm.nih.gov/pubmed/24248060 http://dx.doi.org/10.3390/ijms141122558 |
Ejemplares similares
-
Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification
por: Lauterbach, Edward C.
Publicado: (2016) -
The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
por: Lauterbach, Edward C., et al.
Publicado: (2012) -
The neurotrophic and neuroprotective effects of psychotropic agents
por: Hunsberger, Joshua, et al.
Publicado: (2009) -
Revisiting the neuropsychiatry of Huntington's
disease
por: Teixeira, Antonio Lucio, et al.
Publicado: (2016) -
Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
por: Morigaki, Ryoma, et al.
Publicado: (2017)